Testimonial coming soon...

Reprocell

Company Profile

Location: USA
Product/Service: REPROCELL was established with the goal of contributing to people’s health and welfare through the development of stem cell technologies.
Deal Cycle: 3 – 6 months

Target Profile

Location: USA & Europe
Company Size: Any, but initial focus on larger
Role/Function: Owners & C-suite, or senior figures in R&D, projects and a range of specific scientific areas

Company Description
  • Offer Research Contracts to Pharma companies who would like to test IBD drugs in Reprocell labs. Contract Research Service Offering under the BIOPTA brand
  • REPROCELL’s stem cell services team is a specialized research group with training in stem cell biology received in leading stem cell labs from around the world
  • They will provide exactly the cells needed for investigations, freeing up time and resources to focus on the research
Objectives
  • Focus is to start dialogue with ideally large Pharma companies in the US and EU, initially inviting them for a call around the two core offerings: IBD and Stem Cell IPC
Headline Results

PROSPECTS ENGAGED

OPEN RATE

RESPONSES

LEADS

COST PER LEAD

Campaign Performance Breakdown

Here's how the ccampaign performed across each of the industry verticals and company size brackets in scope.

Sector Prospects Engaged Opened Opened % Responses Response % Leads Lead Rate % Cost Per Lead
Biotechnology 3879 2675 21% 449 12% 155 4% £50.05
Pharmaceuticals 2386 1456 20% 245 10% 49 2% £97.39
Research 215 58 21% 5 2% 1 0% £430.00
Hospital & Health Care 11 8 28% 1 9% 0 0% £0.00

 

# Employees Prospects Engaged Opened Opened % Responses Response % Leads Lead Rate % Cost Per Lead
Myself Only 66 50 22% 10 15% 1 2% £132.00
1-10 employees 1250 1085 25% 215 17% 62 5% £40.32
11-50 employees 1223 906 23% 161 13% 63 5% £38.83
51-200 employees 1202 749 20% 124 10% 39 3% £61.64
201-500 employees 573 279 17% 47 8% 5 1% £229.20
501-1000 employees 410 217 18% 34 8% 8 2% £102.50
1001-5000 employees 568 318 20% 39 7% 5 1% £227.20
5001-10,000 employees 294 188 23% 27 9% 9 3% £65.33
10,001+ employees 899 397 16% 43 5% 13 1% £138.31